{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:13:39Z","timestamp":1779110019908,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T00:00:00Z","timestamp":1343088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hashimoto\u2019s encephalopathy is a poorly understood syndrome consisting of heterogeneous neurological symptoms and high serum antithyroid antibody titers, typically responding to steroids. More clinical series studies are required to characterize the clinical, laboratory and imaging features, and outcomes, especially in the Chinese population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed the clinical, laboratory, and imaging features and outcomes of thirteen consecutive patients with Hashimoto\u2019s encephalopathy diagnosed in Xuan Wu Hospital, Beijing from 2005 to 2010 retrospectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Cognitive impairment (84.6%) and psychiatric symptoms (38.5%) were the most frequent symptoms. Seizures (30.8%) and myoclonus (7.7%) were less common than previously described. Three (23.1%) patients showed abnormal signals in hippocampus or temporal lobe, which were believed related to their memory disorders or seizures. MRI changes showed resolution paralleling clinical improvement in one patient. Among eight patients who received steroid therapy, five patients recovered, one patient improved with residual deficits, and two patients relapsed or had no effect. Among five non-steroid treated patients, three patients experienced stable remission with antiepileptic drugs or general neurotrophic therapy, and two patients experienced continuous deterioration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Most patients with Hashimoto\u2019s encephalopathy showed good response to steroids. Some patients improved without steroid therapy. Considering its reversible course, we recommend that Hashimoto\u2019s encephalopathy should always be in the differential diagnosis while evaluating disorders of the central nervous system.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-12-60","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T18:23:01Z","timestamp":1343154181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hashimoto\u2019s encephalopathy cases: Chinese experience"],"prefix":"10.1186","volume":"12","author":[{"given":"Yi","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"issue":"2","key":"599_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archneur.63.2.197","volume":"63","author":"P Castillo","year":"2006","unstructured":"Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, et al: Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006, 63 (2): 197-202. 10.1001\/archneur.63.2.197.","journal-title":"Arch Neurol"},{"issue":"7462","key":"599_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","volume":"2","author":"L Brain","year":"1966","unstructured":"Brain L, Jellinek EH, Ball K: Hashimoto\u2019s disease and encephalopathy. Lancet. 1966, 2 (7462): 512-514.","journal-title":"Lancet"},{"issue":"8","key":"599_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/BF00900946","volume":"243","author":"I Kothbauer-Margreiter","year":"1996","unstructured":"Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW: Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. 1996, 243 (8): 585-593. 10.1007\/BF00900946.","journal-title":"J Neurol"},{"issue":"10","key":"599_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2165\/00023210-200721100-00002","volume":"21","author":"R Mocellin","year":"2007","unstructured":"Mocellin R, Walterfang M, Velakoulis D: Hashimoto\u2019s encephalopathy : epidemiology, pathogenesis and management. CNS Drugs. 2007, 21 (10): 799-811. 10.2165\/00023210-200721100-00002.","journal-title":"CNS Drugs"},{"issue":"11\u201312","key":"599_CR5","first-page":"591","volume":"49","author":"K Zophel","year":"2003","unstructured":"Zophel K, Saller B, Wunderlich G, Gruning T, Koch R, Wilde J, Mann K, Franke WG: Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin Lab. 2003, 49 (11\u201312): 591-600.","journal-title":"Clin Lab"},{"issue":"2","key":"599_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000008007","volume":"41","author":"R Peschen-Rosin","year":"1999","unstructured":"Peschen-Rosin R, Schabet M, Dichgans J: Manifestation of Hashimoto\u2019s encephalopathy years before onset of thyroid disease. Eur Neurol. 1999, 41 (2): 79-84. 10.1159\/000008007.","journal-title":"Eur Neurol"},{"issue":"8","key":"599_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00415-006-0170-7","volume":"253","author":"F Ferracci","year":"2006","unstructured":"Ferracci F, Carnevale A: The neurological disorder associated with thyroid autoimmunity. J Neurol. 2006, 253 (8): 975-984. 10.1007\/s00415-006-0170-7.","journal-title":"J Neurol"},{"issue":"2","key":"599_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/archneur.60.2.164","volume":"60","author":"JY Chong","year":"2003","unstructured":"Chong JY, Rowland LP, Utiger RD: Hashimoto encephalopathy: syndrome or myth?. Arch Neurol. 2003, 60 (2): 164-171. 10.1001\/archneur.60.2.164.","journal-title":"Arch Neurol"},{"issue":"7","key":"599_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0248-8663(01)00403-9","volume":"22","author":"F Archambeaud","year":"2001","unstructured":"Archambeaud F, Galinat S, Regouby Y, Magy L, Rebeyrotte I, Vallat JM, Teissier MP: Hashimoto encephalopathy. Analysis of four case reports. Rev Med Interne. 2001, 22 (7): 653-659. 10.1016\/S0248-8663(01)00403-9.","journal-title":"Rev Med Interne"},{"issue":"3","key":"599_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1212\/WNL.54.3.769","volume":"54","author":"KW Nolte","year":"2000","unstructured":"Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W: Hashimoto encephalopathy: a brainstem vasculitis?. Neurology. 2000, 54 (3): 769-770. 10.1212\/WNL.54.3.769.","journal-title":"Neurology"},{"issue":"2","key":"599_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jns.2003.09.007","volume":"217","author":"F Ferracci","year":"2004","unstructured":"Ferracci F, Bertiato G, Moretto G: Hashimoto\u2019s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004, 217 (2): 165-168. 10.1016\/j.jns.2003.09.007.","journal-title":"J Neurol Sci"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1196\/annals.1444.018","volume":"1142","author":"N Schiess","year":"2008","unstructured":"Schiess N, Pardo CA: Hashimoto\u2019s encephalopathy. Ann N Y Acad Sci. 2008, 1142: 254-265. 10.1196\/annals.1444.018.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"599_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12 (3): 189-198. 10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"599_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000160155","volume":"86","author":"F He","year":"2008","unstructured":"He F, Guan H, Zhao Z, Miao X, Zhou Q, Li L, Huang D, Liu A, Miao D: Evaluation of short-term psychological functions in opiate addicts after ablating the nucleus accumbens via stereotactic surgery. Stereotact Funct Neurosurg. 2008, 86 (5): 320-329. 10.1159\/000160155.","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"599_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1212\/WNL.49.1.246","volume":"49","author":"NI Bohnen","year":"1997","unstructured":"Bohnen NI, Parnell KJ, Harper CM: Reversible MRI findings in a patient with Hashimoto\u2019s encephalopathy. Neurology. 1997, 49 (1): 246-247. 10.1212\/WNL.49.1.246.","journal-title":"Neurology"},{"issue":"8","key":"599_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1212\/01.WNL.0000090462.62087.A1","volume":"61","author":"P Duffey","year":"2003","unstructured":"Duffey P, Yee S, Reid IN, Bridges LR: Hashimoto\u2019s encephalopathy: postmortem findings after fatal status epilepticus. Neurology. 2003, 61 (8): 1124-1126. 10.1212\/01.WNL.0000090462.62087.A1.","journal-title":"Neurology"},{"issue":"2","key":"599_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1212\/WNL.49.2.623","volume":"49","author":"CM Forchetti","year":"1997","unstructured":"Forchetti CM, Katsamakis G, Garron DC: Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology. 1997, 49 (2): 623-626. 10.1212\/WNL.49.2.623.","journal-title":"Neurology"},{"issue":"1\u20133","key":"599_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-5793(02)03307-0","volume":"528","author":"H Ochi","year":"2002","unstructured":"Ochi H, Horiuchi I, Araki N, Toda T, Araki T, Sato K, Murai H, Osoegawa M, Yamada T, Okamura K, et al: Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto\u2019s encephalopathy. FEBS Lett. 2002, 528 (1\u20133): 197-202.","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"599_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jneuroim.2005.02.004","volume":"162","author":"A Fujii","year":"2005","unstructured":"Fujii A, Yoneda M, Ito T, Yamamura O, Satomi S, Higa H, Kimura A, Suzuki M, Yamashita M, Yuasa T, et al: Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto\u2019s encephalopathy. J Neuroimmunol. 2005, 162 (1\u20132): 130-136.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"599_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jns.2003.08.005","volume":"217","author":"T Oide","year":"2004","unstructured":"Oide T, Tokuda T, Yazaki M, Watarai M, Mitsuhashi S, Kaneko K, Hashimoto T, Ohara S, Ikeda S: Anti-neuronal autoantibody in Hashimoto\u2019s encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients. J Neurol Sci. 2004, 217 (1): 7-12. 10.1016\/j.jns.2003.08.005.","journal-title":"J Neurol Sci"},{"issue":"2","key":"599_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00415-005-0925-6","volume":"253","author":"P Striano","year":"2006","unstructured":"Striano P, Pagliuca M, Andreone V, Zara F, Coppola A, Striano S: Unfavourable outcome of Hashimoto encephalopathy due to status epilepticus. One autopsy case. J Neurol. 2006, 253 (2): 248-249. 10.1007\/s00415-005-0925-6.","journal-title":"J Neurol"},{"issue":"4","key":"599_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/08916930410001708751","volume":"37","author":"A Vincent","year":"2004","unstructured":"Vincent A, Rothwell P: Myasthenia gravis. Autoimmunity. 2004, 37 (4): 317-319. 10.1080\/08916930410001708751.","journal-title":"Autoimmunity"},{"issue":"1\u20132","key":"599_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2007.08.012","volume":"192","author":"S Blanchin","year":"2007","unstructured":"Blanchin S, Coffin C, Viader F, Ruf J, Carayon P, Potier F, Portier E, Comby E, Allouche S, Ollivier Y, et al: Anti-thyroperoxidase antibodies from patients with Hashimoto\u2019s encephalopathy bind to cerebellar astrocytes. J Neuroimmunol. 2007, 192 (1\u20132): 13-20.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"599_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jpsychores.2005.04.002","volume":"59","author":"A Engum","year":"2005","unstructured":"Engum A, Bjoro T, Mykletun A, Dahl AA: Thyroid autoimmunity, depression and anxiety; are there any connections? an epidemiological study of a large population. J Psychosom Res. 2005, 59 (5): 263-268. 10.1016\/j.jpsychores.2005.04.002.","journal-title":"J Psychosom Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-12-60\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:38:26Z","timestamp":1630525106000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-12-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-12-60","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]},"assertion":[{"value":"22 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}